Central Laboratories White Papers & Articles

  1. Harnessing RWE For Effective External Control Arms In Clinical Trials 3/24/2025

    Real-world evidence (RWE) is transforming clinical trials by enabling the use of external control arms (ECAs), which serve as an alternative to traditional randomized control groups.

  2. Advancing Neuroscience Research With Data-Driven Innovations And AI 3/24/2025

    Learn how to employ data-driven insights, artificial intelligence, and decentralized clinical trials to accelerate drug development and address the intricate challenges of neuroscience research.

  3. The Hidden Complexity Of Ophthalmic Protocol Requirements 3/21/2025

    Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.

  4. Navigating Regulatory And Privacy Updates In Clinical Trials 3/21/2025

    Explore how the guide for eRegulatory adoption in Canada provides resources to help stakeholders navigate these changes and enhance participant engagement and retention in clinical trials.

  5. Do CROs Need To Reinvent Themselves In 2025? 3/21/2025

    Facing economic pressures, regulatory changes, and technological advancements, CROs must redefine their value propositions and discuss the need for reinvention in 2025 to accelerate into the future.

  6. Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call 3/21/2025

    Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

  7. Life Sciences Companies Talk Past, Present, And Future At JPM 3/21/2025

    The 43rd annual J.P. Morgan Healthcare Conference featured presentations from a host of large, medium, and small-cap life sciences companies that discussed past performance and future outlooks.

  8. How Healthy Is Your TMF? A Check-In Before An Inspection 3/18/2025

    Explore how proper oversight of the Trial Master File (TMF) prevents inspection findings. Regular reviews, heatmaps, and risk-based assessments help ensure TMF health, and readiness for regulatory inspections.

  9. Five Key Trends In CMC 3/18/2025

    CMC is evolving with digitalization, sustainability, supply chain resilience, post-merger integration, and personalized medicine.

  10. The Important Role Of The Study Owner In Guiding The TMF 3/18/2025

    Learn about the critical role that a study owner plays in maintaining Trial Master File (TMF) oversight, ensuring compliance, and driving collaboration across clinical study teams.